Structures by: Minnih M. S.
Total: 6
(4<i>Z</i>)-1-Benzyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C19H18N2O2
IUCrData (2018) 3, 2 x180326
a=8.9229(5)Å b=18.8922(10)Å c=9.7147(5)Å
α=90° β=104.8790(10)° γ=90°
(4<i>Z</i>)-4-[1-(2-Aminoanilino)ethylidene]-3-methyl-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazol-5-one
C18H18N4O
IUCrData (2017) 2, 2 x170256
a=8.6575(2)Å b=7.17490(10)Å c=25.3062(5)Å
α=90° β=93.7820(10)° γ=90°
(4<i>Z</i>)-1-Benzyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C19H18N2O2
IUCrData (2016) 1, 9 x161448
a=8.2829(2)Å b=13.8636(4)Å c=15.1292(4)Å
α=72.3280(10)° β=74.9220(10)° γ=87.2520(10)°
3-Chloro-2-ethyl-6-nitro-2<i>H</i>-indazole
C9H8ClN3O2
IUCrData (2017) 2, 5 x170652
a=11.2363(7)Å b=7.4063(5)Å c=12.1247(8)Å
α=90° β=111.0510(10)° γ=90°
1-(3-Bromo-6-nitro-1<i>H</i>-indazol-1-yl)ethan-1-one
C9H6BrN3O3
IUCrData (2017) 2, 5 x170660
a=13.9863(5)Å b=7.8783(3)Å c=18.5549(7)Å
α=90° β=100.7860(10)° γ=90°
3-(4,4-Dimethyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-ylidene)-6-methyl-3,4-dihydro-2<i>H</i>-pyran-2,4-dione
C17H18N2O3
Acta Crystallographica Section E (2019) 75, 2 228-232
a=5.53730(10)Å b=24.0197(4)Å c=11.7815(3)Å
α=90° β=103.488(2)° γ=90°